An Antibody-Drug Conjugate That Selectively Targets Human Monocyte Progenitors for Anti-Cancer Therapy
As hematopoietic progenitors supply a large number of blood cells, therapeutic strategies targeting hematopoietic progenitors are potentially beneficial to eliminate unwanted blood cells, such as leukemic cells and immune cells causing diseases. However, due to their pluripotency, targeting those ce...
Main Authors: | Yuta Izumi, Masashi Kanayama, Zhongchuzi Shen, Masayuki Kai, Shunsuke Kawamura, Megumi Akiyama, Masahide Yamamoto, Toshikage Nagao, Keigo Okada, Norihiko Kawamata, Shigeo Toyota, Toshiaki Ohteki |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.618081/full |
Similar Items
-
Anti-Leukemic Properties of Histamine in Monocytic Leukemia: The Role of NOX2
by: Roberta Kiffin, et al.
Published: (2018-06-01) -
Classification of Monocytes, Promonocytes and Monoblasts Using Deep Neural Network Models: An Area of Unmet Need in Diagnostic Hematopathology
by: Mazen Osman, et al.
Published: (2021-05-01) -
Concurrent juvenile myelomonocytic leukemia with thalassemia in a case with Plasmodium knowlesi infection from Sabah, Malaysian Borneo
by: Mimi Azreen Abdullah, et al.
Published: (2019-06-01) -
Multiple skin metastases in a patient with acute myelomonocytic leukemia
by: Daye Munise, et al.
Published: (2019-01-01) -
Evaluation by Flow Cytometry of Mature Monocyte Subpopulations for the Diagnosis and Follow-Up of Chronic Myelomonocytic Leukemia
by: Tiphanie Picot, et al.
Published: (2018-04-01)